Condition: Crohn Disease · Sponsor: Austin Health
The purpose of this study is to evaluate the safety of vagal nerve neuromodulation in a cohort of patients operated on for Crohn's disease, in a prospective, single centre, cohort study.
This description comes directly from the study's public registry record.
Peter De Cruz, MBBS PhD FRACP · +61 3 9496 6233 · Peter.DeCruz@austin.org.au
Raquel Pena, B.Pharm, CTC · +61 3 9496 5327 · IBDtrials@austin.org.au
Always discuss trial participation with your own doctor first.
| Austin Health | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05469607